Anderson; W. H. Kerr

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anderson; W. H. Kerr.The latest application filed is for "uses of cationic hydroxyethylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders".

Company Profile

1.10.10

Anderson; W. H. Kerr - Midland MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Plant production of immunoglobulins with reduced fucosylation Grant 8,106,169 - Briggs , et al. January 31, 2	2012-01-31
Uses Of Cationic Hydroxyethylcellulose In Oral Ingestion Forms, And Prevention And Treatment Of Metabolic Disorders App 20100331278 - Anderson; W. H. Kerr ; et al.	2010-12-30
Plant production of immunoglobulins with reduced fucosylation App 20070089201 - Briggs; Kristen ; et al.	2007-04-19
High affinity humanized anti-tag-72 monoclonalantibodies Grant 6,753,152 - Anderson , et al. June 22, 2	2004-06-22
High affinity humanized anti-Tag-72 monoclonal antibodies Grant 6,753,420 - Anderson , et al. June 22, 2	2004-06-22
High affinity humanized anti-TAG-72 monoclonal antibodies Grant 6,752,990 - Anderson , et al. June 22, 2	2004-06-22
High affinity humanized anti-TAG-72 monoclonal antibodies Grant 6,737,060 - Anderson , et al. May 18, 2	2004-05-18
High affinity humanized anti-TAG-72 monoclonal antibodies Grant 6,737,061 - Anderson , et al. May 18, 2	2004-05-18
Probing method for identifying antibodies specific for selected antigens Grant 6,641,999 - Mezes , et al. November 4, 2	2003-11-04
High affinity humanized anti-CEA monoclonal antibodies App 20030027994 - Anderson, W. H. Kerr ; et al.	2003-02-06
High affinity humanized anti-CEA monoclonal antibodies App 20030018171 - Anderson, W.H Kerr ; et al.	2003-01-23
High affinity humanized anti-TAG-72 monoclonalantibodies App 20030013856 - Anderson, W.H. Kerr ; et al.	2003-01-16
High affinity humanized anti-TAG-72 monoclonalantibodies App 20030013854 - Anderson, W. H. Kerr ; et al.	2003-01-16
High affinity humanized anti-tag-72 monoclonalantibodies App 20030004318 - Anderson, W. H. Kerr ; et al.	2003-01-02
High affinity humanized anti-tag-72 monoclonalantibodies App 20020193574 - Anderson, W. H. Kerr ; et al.	2002-12-19
High affinity humanized anti-CEA monoclonal antibodies App 20020183495 - Anderson, W. H. Kerr ; et al.	2002-12-05
High affinity humanized anti-TAG-72 monoclonalantibodies App 20020183497 - Anderson, W. H. Kerr ; et al.	2002-12-05
High affinity humanized anti-CEA monoclonal antibodies Grant 6,417,337 - Anderson , et al. July 9, 2	2002-07-09
High affinity humanized anti-TAG-72 monoclonalantibodies Grant 6,348,581 - Anderson , et al. February 19, 2	2002-02-19
Family of high affinity, modified antibodies for cancer treatment Grant 5,993,813 - Mezes , et al. November 30, 1	1999-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.